ArticleJournal of the American Heart Association2022

Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes-Induced Atherosclerotic Plaque Instability.

Yung-Chih Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.